Abstract
Purpose
To investigate the effects of combination treatment with levothyroxine (LT4) and l- triiodothyronine (LT3) on left atrial volume (LAV), diastolic functions, and atrial electro-mechanical delays in LT4-treated women with low triiodothyronine (T3) levels.
Methods
This prospective study consisted of 47 female patients between 18 and 65 years old treated at an Endocrinology and Metabolism outpatient clinic between February and April 2022 due to primary hypothyroidism. The study included patients with persistently low T3 levels in at least three measurements, despite LT4 treatment (1.6–1.8 mcg/kg/m2) for 23.13 ± 6.28 months with normal thyrotropin (TSH) and free tetraiodothyronine (fT4) levels. The combination therapy dose was as follows: the fixed LT4 dose (25 mcg) was removed from patients’ usual LT4 treatment [100 mcg (min–max, 75–150)], and a fixed LT3 dose (12.5 mcg) was added. Biochemical samples were taken, and an echocardiographic assessment was performed for patients upon their first admission, and after 195.5 ± 12.8 days of receiving LT3 (12.5 mcg) treatment.
Results
There was a statistically significant reduction at left ventricle (LV) end-systolic diameter (27.69 ± 3.14, 27.13 ± 2.89, p = 0.035), left atrial (LA) maximum volume (14.73 ± 3.22, 13.94 ± 3.15, p = 0.009), LA minimum volume (7.84 ± 2.45, 6.84 ± 2.30, p < 0.001), LA vertical diameter (44.08 ± 6.92, 34.60 ± 4.31, <0.001), LA horizontal diameter (45.65 ± 6.88, 33.43 ± 4.51, p < 0.001), LAVI (50.73 ± 18.62, 41.0 ± 13.02, p < 0.001), total conduction time (103.69 ± 12.70, 79.82 ± 18.40, p < 0.001) after LT3 replacement (respectively pre-post- treatment and p value).
Conclusion
In conclusion, the findings of this study suggest that the addition of LT3 to LT4 treatment may lead to improvements in LAVI and atrial conduction times in patients with low T3. However, further research with larger patient groups and exploration of different LT4 + LT3 dose combinations is needed to better understand the effects of combined hypothyroidism treatment on cardiac functions.
Similar content being viewed by others
References
C.G. Roberts, P.W. Ladenson, Hypothyroidism. Lancet 363, 793–803 (2004). https://doi.org/10.1016/S0140-6736(04)15696-1
J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 24, 1670–1751 (2014). https://doi.org/10.1089/thy.2014.0028
W.M. Wiersinga, L. Duntas, V. Fadeyev, B. Nygaard, M.P.J. Vanderpump, 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur. Thyroid J. 1, 55–71 (2012). https://doi.org/10.1159/000339444
C. Dayan, V. Panicker, Management of hypothyroidism with combination thyroxine (T4) and triiodothyronine (T3) hormone replacement in clinical practice: a review of suggested guidance. Thyroid Res 11, 1 (2018). https://doi.org/10.1186/s13044-018-0045-x
S.J. Lee, J.G. Kang, O.H. Ryu, C.S. Kim, S. Ihm, M.G. Choi et al. The relationship of thyroid hormone status with myocardial function in stress cardiomyopathy. Eur. J. Endocrinol. 160(5), 799–806 (2009). https://doi.org/10.1530/EJE-08-0808
K. Otani, M. Takeuchi, K. Kaku, N. Haruki, H. Yoshitani, M. Tamura et al. Impact of diastolic dysfunction grade on left atrial mechanics assessed by two-dimensional speckle tracking echocardiography. J. Am. Soc. Echocardiogr. 23, 961–967 (2010). https://doi.org/10.1016/j.echo.2010.06.023
T.S.M. Tsang, M.E. Barnes, B.J. Gersh, K.R. Bailey, J.B. Seward et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am. J. Cardiol. 90, 1284–1289 (2002). https://doi.org/10.1016/s0002-9149(02)02864-3
A. Hosseinsabet, Assessment of atrial conduction times in patients with mild diastolic dysfunction and normal atrial size. Anatol. J. Cardiol. 15, 925–931 (2015). https://doi.org/10.5152/akd.2014.5816
M. Tadic, S. Ilic, B. Ivanovic, V. Celic, Left atrial phasic function and mechanics in women with subclinical hypothyroidism: the effects of levothyroxine therapy. Echocardiography 31, 1221–1229 (2014). https://doi.org/10.1111/echo.12554
F. Kosar, I. Sahin, N. Turan, E. Topal, Y. Aksoy, C. Taskapan et al. Evaluation of right and left ventricular function using pulsed-wave tissue Doppler echocardiography in patients with subclinical hypothyroidism. J. Endocrinol. Invest 28, 704–710 (2005). https://doi.org/10.1007/BF03347553
S. Ozturk, O. Dikbas, M. Ozyasar, S. Ayhan, F. Ozlu, D. Baltaci et al. Evaluation of left atrial mechanical functions and atrial conduction abnormalities in patients with clinical hypothyroid. Cardiol. J. 19, 287–294 (2012). https://doi.org/10.5603/cj.2012.0051
P.W. Cylde, A.E. Harari, E.J. Getka, K.M.M. Shakir, Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA 290(22), 2952–2958 (2003). https://doi.org/10.1001/jama.290.22.2952
H.F. Escobar-Morreale, J. Botella-Carretero, M. Gomez-Bueno, J.M. Galan, V. Barrios, J. Sancho, Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann. Intern Med 142, 412–424 (2005). https://doi.org/10.7326/0003-4819-142-6-200503150-00007
B. Biondi, L. Wartofsky, Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? J. Clin. Endocrinol. Metab. 97(7), 2256–2271 (2012). https://doi.org/10.1210/jc.2011-3399
T. Rodriguez, V.R. Lavis, J.C. Meininger, A.S. Kapadia, L.F. Stafford, Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with thyroxine alone. Endocr. Pr. 11(4), 223–233 (2005). https://doi.org/10.4158/EP.11.4.223
P. Saravanan, H. Siddique, D.J. Simmons, R. Greenwood, C.M. Dayan, Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy. Exp. Clin. Endocrinol. Diabetes 115(4), 261–267 (2007). https://doi.org/10.1055/s-2007-973071
J. Jonklaas, K.D. Burman, Daily administration of short acting liothyronine is associated with significant triiodothyronine excursions and fails to alter thyroid responsive parameters. Thyroid.: Off. J. Am. Thyroid. Assoc. 26(6), 770–778 (2016). https://doi.org/10.1089/thy.2015.0629
B. Van Tassell, G.F. Wohlford, J.D. Linderman, S. Smith, S. Yavuz, Pucino et al. Pharmacokinetics of L-Triiodothyronine in patients undergoing thyroid hormone therapy withdrawal. Thyroid 29(10), 1371–1379 (2019). https://doi.org/10.1089/thy.2019.0101
P.J.D. Owen, R. Sabit, J.H. Lazarus, Thyroid disease and vascular function. Thyroid 17, 519–524 (2007). https://doi.org/10.1089/thy.2007.0051
S.F. Nagueh, C.P. Appleton, T.C. Gillebert, P.N. Marino, J.K. Oh, O.A. Smiseth et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur. J. Echocardiogr. 10, 165–193 (2009). https://doi.org/10.1093/ejechocard/jep007
G. Acar, A. Akcay, A. Sokmen, M. Ozkaya, E. Guler, G. Sokmen et al. Assessment of atrial electromechanical delay, diastolic functions, and left atrial mechanical functions in patients with type 1 diabetes mellitus. J. Am. Soc. Echocardiogr. 22, 732–738 (2009). https://doi.org/10.1016/j.echo.2009.03.028
A.R. Cappola, L.P. Fried, A.M. Arnold, M.D. Danese, L.H. Kuller, G.L. Burke et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295, 1033–1041 (2006). https://doi.org/10.1001/jama.295.9.1033
D.S. Cooper, B. Biondi, Subclinical thyroid disease. Lancet 379, 1142–1154 (2012). https://doi.org/10.1016/S0140-6736(11)60276-6
Y. Meng, T. Zhao, Z. Zhang, S. Zhang, Association between sub-clinical hypothyroidism and heart failure with preserved ejection fraction. Chin. Med J. (Engl.) 133, 364–366 (2020). https://doi.org/10.1097/CM9.0000000000000631
Author information
Authors and Affiliations
Contributions
İ.B. and A.E. were responsible for the design, management, data collection, analysis, and writing of the study. S.F. was involved in the design of the study and data collection. C.İ.S. was responsible for methodology, analysis. I.D.K. and I.T. were involved in formal analysis, supervision, writing - review, and editing. All authors read and approved the final paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Consent to publish/participate
Written informed consent was obtained from all individual participants included in the study.
Ethical approval
This study was conducted according to the principles of the Helsinki Declaration after it was approved by the ethical committee of Medical Faculty of Pamukkale University, Denizli, Turkiye (25.01.22/02).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Buber, I., Eraydin, A., Sevgican, C.I. et al. The effects of combination treatment with LT4 and LT3 on diastolic functions and atrial conduction time in LT4-treated women with low T3: a short term follow-up study. Endocrine 81, 316–321 (2023). https://doi.org/10.1007/s12020-023-03363-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-023-03363-1